entertainment -WSS

entertainment

author：knowledge 2025-09-14 10:08:11 - browse：63974

The building exterior of AstraZeneca, a pharmaceutical and biopharmaceutical company, under cloudless blue sky — coverage from STAT — Adobe

WILMINGTON, Del. — Wednesday was the first time that a federal judge asked questions in-person of drug industry lawyers who are trying to stop Medicare from negotiating drug prices. It didn’t go well for them.

AstraZeneca’s lawyers argued that Medicare’s new powers amount to a taking of their property rights without due process. But Colm Connolly, chief judge of the U.S. District Court of Delaware, said he doesn’t understand how the law deprives AstraZeneca of its property. He asked Catherine Stetson, who represents AstraZeneca, multiple times to explain what property the company would lose due to Medicare price negotiation. Stetson said it’s both the patent and the drug that’s subject to the patent.

“You’re free to do what you want,” Connolly said, adding that drug companies don’t have to sell to Medicare. “You may not make as much money.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban
Next article： A revolution in caring for preterm infants

Wikipedia

focus

WSS

Takeaways from AdvaMed, the largest medical devices conference

Medicare explains how it will choose drugs for negotiation

NYU Langone launches private ChatGPT for its health care data

NYU Langone launches private ChatGPT for its health care data

Readout LOUD podcast: Merger Mondays, Ozempic panic

Radiation, mainstay of cancer treatment, begins a fade

Wikipedia

entertainment

Wikipedia

In age of alternative facts, a scholarly course on calling out crap

Winners, losers from Medicare’s list of drugs subject to price talks

Bright Health sells Medicare Advantage business to Molina

Nick Jonas talks about managing diabetes along with his career

State Dept. review finds Biden bears some blame for Afghanistan failures

There’s no way to know how good AI health technologies are

Apple is now the first public company to be valued at $3 trillion

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

At least 13 dead in Texas as scorching temps continue

Readout LOUD podcast: Merger Mondays, Ozempic panic

hotspot

Neuroscience startup Neumora files for IPO

What do new weight loss drugs mean for bariatric surgery?

Feds fine Medicare Advantage plans for overcharging members

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

In science, is the line between industry and academia shifting?

Feds fine Medicare Advantage plans for overcharging members

leisure time

Wikipedia

focus

focus